| KMV | killed measles virus vaccine |
|---|---|
| LVV | left ventricular volume; Le Veen valve; live varicella vaccine; live varicella virus |
| PLV | partial liquid ventilation; poliomyelitis live vaccine; panleukopenia virus; phenylalanine, lysine, ... |
| PPV | pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur... |
| PV | pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc... |
| encephalitis viruses | A collection of single-stranded RNA viruses scattered across the bunyaviridae, flaviviridae, and togaviridae families whose common property is the ability to induce encephalitic conditions in infected hosts. (12 Dec 1998) |
|---|---|
| encephalitis viruses, tick-borne | A subgroup of the genus flavivirus that causes encephalitis and haemorrhagic fevers and is found in eastern and western europe and the former soviet union. It is transmitted by tick vectors and there is an associated milk-borne transmission from viraemic cattle, goats, and sheep. (12 Dec 1998) |
| epidemic encephalitis | A viral encephalitis occurring epidemically, such as in Japanese B encephalitis, St. Louis encephalitis, and lethargic encephalitis. (05 Mar 2000) |
| equine encephalitis | <veterinary> An acute, often fatal, virus disease of horses and mules transmitted by mosquitoes and characterised by central nervous system disturbances. It is typically caused by one of two arthropod-borne viruses, and their resulting diseases are designated western equine or eastern equine encephalomyelitis; these viruses belong to the family Togaviridae and can also cause neurologic disease in humans. Synonym: equine encephalitis. (05 Mar 2000) |
| experimental allergic encephalitis | <pathology> An autoimmune disease that can be induced in various experimental animals by the injection of homogenised brain or spinal cord in Freund's adjuvant. The antigen appears to be a basic protein present in myelin and the response is characterised by focal areas of lymphocyte and macrophage infiltration into the brain, associated with demyelination and destruction of the blood-brain barrier. Sometimes used as a model for demyelinating diseases, although whether this is entirely justifiable is not clear. (18 Nov 1997) |
| Far East Russian encephalitis | Tick-borne encephalitis (Eastern subtype). (05 Mar 2000) |
| fox encephalitis | Encephalitis in foxes, caused by the infectious canine hepatitis virus, a member of the family Adenoviridae family, and characterised by paralysis and death. (05 Mar 2000) |
| lead encephalitis | A metabolic encephalopathy, caused by the ingestion of lead compounds and seen particularly in early childhood; it is characterised pathologically by extensive cerebral oedema, status spongiosus, neurocytolysis, and some reactive inflammation; clinical manifestations include convulsions, delirium, and hallucinations. See: lead poisoning. Synonym: lead encephalitis, saturnine encephalopathy. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
| bacillus Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| BCG vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|